228850 — Rayence Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapNeutral

Annual cashflow statement for Rayence Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,093	21,849	19,462	7,749	-5,321
Depreciation
Amortisation
Non-Cash Items	15,095	6,406	3,007	2,806	5,170
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-14,922	-16,602	-773	8,949	4,586
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	20,939	16,607	25,820	24,839	9,207
Capital Expenditures	-2,188	-1,920	-4,341	-8,362	-2,338
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-18,092	3,102	-16,591	38.2	-11,435
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-20,280	1,182	-20,933	-8,324	-13,772
Financing Cash Flow Items	—	1,239	0	-13,683	212
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,389	-3,624	-3,691	-17,262	-3,022
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,254	13,030	923	865	-7,495